Convergence Partners

That is a wrap! 2024 Report: CHF +40 million by Convergence Partners’ portfolio companies. ⚡ Our 2024 has taken us across the world, establishing energizing collaborations, and generating further progress in #MentalHealth & #BrainHealth solutions. 👋 From our team, thank you for joining us on this journey! Daniel Koppelkamm, CFA, Pascal Joncour, Rajnesh Airey, Nicolas L. Kiep #TMS #Psychedelics #DigitalHealth #Biotech #VentureCapital #Events

🚀 Unlocking the Brain-Gut Axis: Innovation at the Forefront in #Davos with REGEnLIFE 🙌 Thrilled to share insights from an engaging discussion Convergence Partners Partner, Pascal Joncour, had with REGEnLIFE CIO Guillaume Blivet at the Brain House in #Davos. We delved into RegenLife's pioneering work on the brain-gut connection and its profound implications for neurological conditions and overall brain health. REGEnLIFE is developing a groundbreaking technology that sheds new light on how the gut microbiome directly influences brain function. This innovative approach has the potential to #revolutionize how we understand and treat neurological conditions, enhance cognitive performance, and optimize brain and mental health. During our conversation, Guillaume Blivet highlighted key areas of interest for investors and strategic partners: 👉 Scientific Validation: Rigorous clinical trials and research to demonstrate the efficacy of their technology. 👉 Market Potential: Addressing a significant and growing need for effective brain health solutions. 👉 Scalability: Developing a platform capable of reaching a broad audience through various applications. The brain-gut axis represents a frontier in medical science, and RegenLife is positioned to be a leader in this space. Their work aligns with the increasing focus on holistic approaches to healthcare, offering a compelling opportunity for those looking to invest in #medtech and #neurotech. I encourage you to watch the full interview https://lnkd.in/dvn2KA79 to learn more about REGEnLIFE's technology and vision. Let's connect to discuss the potential of this groundbreaking research and its impact on the future of brain health. #BrainGutAxis #CognitiveHealth #BrainHealth #RegenLife #Davos #BrainHouse #Innovation #Neurology #Microbiome #VentureCapital #Investment #Healthcare #FutureofMedicine #Science #Technology #HealthTech #MentalTech #Neurotech

🚀 We were thrilled to participate in the Brain House at Davos a few weeks ago! It was an #invaluable opportunity to connect with global leaders and innovators in the brain and mental health space. 🙌 Our Managing Partner, Daniel Koppelkamm, CFA , was interviewed at the Brain House, where he discussed Convergence Partners' strategic approach to venture capital. We're proud to be a #leading investor in the brain and mental health sector, focusing on investments that drive innovation and positive change. We believe that targeted investments in this sector can unlock significant #advancements in neuroscience and mental wellness. Daniel's insights highlighted our commitment to supporting #groundbreaking companies and individuals dedicated to improving lives. We are #committed to driving innovation and fostering collaboration. If you're an LP, VC, startup, or private investor passionate about brain and mental health, we encourage you to connect and explore potential synergies! 😁 👏 #brainhealth #mentalhealth #venturecapital #davos #convergencepartners #impactinvesting #healthtech #innovation Check out the full interview here: https://lnkd.in/dwGJAeWq

Missed Mental Health Day in Davos last week? #WEF2025 Watch the playbacks now. 👉🏼 Pitch Sessions: Global Leaders in Brain & Mental Health Innovation with Daniel Koppelkamm, CFA, REGEnLIFE, neotiv, SwissDTx™, and Laura Johnson 🔗 https://lnkd.in/eS6dZSDc 👉🏼 Brain Science: AI & Digital Tech Breakthroughs in Mental & Brain Health Innovation with Pascal Joncour, Wyss Center for Bio and Neuroengineering, Dandelion Science, and Crisis Text Line 🔗 https://lnkd.in/e88ficuu #MentalHealth #BrainHealth #DTx #Innovation #VentureCapital Shawn Lesser Catalyst Now Heather Kelly Nicolas L. Kiep

🌟#MentalHealthDay in Davos sparked numerous thought-provoking ideas to advance the brain health movement🌟 Yesterday, our Director, Erwin Böttinger, along with Adam Hanina (Dandelion Science), Margaret Meagher, and Pascal Joncour, explored how innovative neurotechnologies are transforming #mentalhealth care. They discussed ways to personalize treatment, enhance brain function, and address conditions like depression, anxiety, and ADHD. The session highlighted evidence-based approaches such as #neuromodulation, digital therapeutics, and #AI advancements, showcasing their potential to revolutionize mental health outcomes. Laura Johnson, from our partner organization BrainScape Medical, joined Daniel Koppelkamm, CFA, Guillaume Blivet, Dr. Chris Rehse, and Matthias Gutknecht to present groundbreaking solutions in brain health. These founders and industry leaders provided critical insights into the globally growing needs for prevention, management, and treatment in the field. 🌍Thank you Convergence Partners and THE REAL Mental Health Foundation for providing a space to shape a new era of targeted, effective, and accessible mental health solutions! #WEF25 #Davos #MHDinDAVOS #Neurotech #BrainHealth

And so it happened. Yesterday BrainScape announced to Davos and beyond at the WEF the BrainScape platform, built on the amazing Epios technology. The Wolrd Economic Forum is a truly weird and wonderful experience. I’ve never been so close to so many Billions of dollars 💵 and so far from them at the same time 🙃 Our flagship solution will change the care path of patients with chronic brain disorders from Random Touch Point Care (inefficient) to continuous objective data based care (efficient) because of a very new way to do continuous, long term EEG. Exciting times. Thank you to everyone for their interest in BrainScape! We aim not to disappoint. Huge 🙏 to the Wyss Center for Bio and Neuroengineering, Erwin Böttinger and Tracy Laabs, PhD for your amazing support in Davos and to get the Epios technology this far. Thanks Convergence Partners and THE REAL Mental Health Foundation for the invite and stage time. #MHDinDAVOS #brainhealth #innovation #eeg #mentalhealth

NEW INVESTMENT IN PROSOMA Today, on World Cancer Day, we are thrilled to announce our 10. Mental & Brain Health investment! We are participating in the €4.4 million Pre-Series A round in Prosoma, a groundbreaking health tech company dedicated to improving the quality of life for cancer patients. Prosoma's innovative platform, Living Well Plus, provides personalized psychological and behavioral support, significantly reducing anxiety, stress, and depression in oncology patients. This investment marks a crucial step in expanding Prosoma's impact, enabling them to strengthen their position in the DACH region, establish a strong foothold in the US market and explore new reimbursement opportunities. Convergence will actively support the internationalisation of Prosoma to the US and Asia. Congratulations to the Prosoma's founder team: Marek Ostrowski, Emanuela Kufel, Andrzej Karcz Jończyk, M.D. We are delighted to partner with fellow investors: Impact Ventures, Verge HealthTech Fund, Smartlink Partners, Simpact Ventures, and a distinguished group of existing VCs and private investors. https://lnkd.in/dkFUdVdz

💡 Mental Health Ecosystem in Davos! Please meet Guillaume Blivet from REGEnLIFE #WEF2025 #MHDinDAVOS Join us next week in Davos during the World Economic Forum to discuss the future of neurodegenerative diseases! 📍 When: Wednesday, January 22nd, 2025 📍 Location: Social Innovation House, Promenade 57, Davos 🔗 Register by January 20th: thereal.care/davos 🎯 Learn More about REGEnLIFE REGEnLIFE is a French medtech and neurotech company at the forefront of neuroscience innovation, using phototherapy for non-invasive brain-gut stimulation. This novel method shows potential in treating neuroinflammation-related diseases such as #Alzheimer's, depression, concussion, and multiple sclerosis. Their cutting-edge device, targeting both brain and gut, aims to enter the neurological disease and mental health market by 2026. Preclinical studies demonstrated safety and efficacy in Alzheimer's, multiple sclerosis, and depression models. First-in-human trials showed promising results in Alzheimer's and sport-related concussion. The company has secured over €8M in pre-series A funding since its incorporation in 2016 and is now seeking €10M in series A funding to further their advancements. This investment will drive them towards achieving their development goals and potentially revolutionizing brain and mental health. #MentalHealth #Startups #BrainHealth #VentureCapital

💪6 days until #MHDinDavos. Wondering what's in the bag? Make sure to sign up for Mental Health Day (new sessions added)! 👉 See Full Agenda: thereal.care/davos 👉 Sign Up for THE REAL Walks: https://lu.ma/shnor9fs 👉 See All Side Events: app.davosweek.com Convergence Partners, THE REAL Mental Health Foundation, Catalyst Now, unDavos Summit, Mark Turrell, Daniel Koppelkamm, CFA, Shawn Lesser, Amer Vohora, Nicolas L. Kiep, Heather Kelly, Pascal Joncour #MentalHealth #WEF25

💡 Exciting Developments in Neurotech! Please meet Adam Hanina from Dandelion Science #WEF2025 #MHDinDAVOS Join us next week in Davos during the World Economic Forum to discuss the future of AI and DTx in Mental Health! 📍 When: Wednesday, January 22nd, 2025 📍 Location: Social Innovation House, Promenade 57, Davos 🔗 Register by January 20th: thereal.care/davos 🧠 Learn More About Dandelion: Dandelion Science is a US-Swiss Generative #Neuromodulation company, committed to advancing precision therapies for vision and brain disorders. Led by a world-class team, Dandelion's mission is to enhance the lives of people affected by these conditions through the integration of advanced generative technologies and deep scientific expertise. The company boasts extensive intellectual property and has received prestigious funding from the #US National Institutes of Health and the Swiss Innovation Agency. #MentalHealth #BrainHealth #Research #Innovation